ChrisTheodossiouMD

Oncology • Jefferson, LA

Breast Cancer, Hematologic Oncology

Staff Oncologist, Ochsner Clinic Foundation

Join to view full profile

Dr. Theodossiou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Theodossiou's full profile

Already have an account?

Office
1514 Jefferson Hwy
Jefferson, LA 70121
Phone+1 504-842-3910

Fax+1 504-842-4533
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1990 - 1992
Grant Hospital of ChicagoResidency, Internal Medicine, 1987 - 1990
University of AthensClass of 1984

Certifications & Licensure

LA State Medical License 1995 - 2024
AL State Medical License 2020 - 2020
MD State Medical License 1993 - 2017
IL State Medical License 1988 - 1993
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Combination of weekly chest radiotherapy and oral vinorelbine for the palliation of advanced non small cell lung cancer: A phase I/II study.
Schwarzenberger PO, Fariss A, Linaris L, Millet A, Zakris E, Murillo R, Theodossiou CG, Nedzi L> ;J. Clin. Oncol.. 2005-06-01
7 citations
Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small-cell lung cancer: a phase I study.
Paul Schwarzenberger, Chris Theodossiou, Scott Barron, Lisa Diethelm, Michael Boyle, Lynn Harrison, Raymond B. Wynn, Omar M. Salazar, Anna Fariss> ;American Journal of Clinical Oncology. 2004 Aug 1
6 citations
Non-Hodgkin's lymphomas.
Chris Theodossiou, Paul Schwarzenberger> ;Clinical Obstetrics and Gynecology. 2002 Sep 1
10 citations
Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem Cells
Qiu Zhong, Peter Oliver, Weishan Huang, David A. Good, V. F. La Russa, Zili Zhang, J. R. Cork, R. W. Veith, C. Theodossiou, Jay K. Kolls, Paul Schwarzenberger> ;Journal of Virology. 2001 Nov 1
15 citations
Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells.
Paul Schwarzenberger, Weitao Huang, Peter Oliver, Chris Theodossiou, Tolu Osidipe, Jay K. Kolls> ;The American Journal of the Medical Sciences. 2001 Feb 1
20 citations
Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model.
Chris Theodossiou, Paul Schwarzenberger> ;The American Journal of the Medical Sciences. 2000 Feb 1
43 citations
Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice.
Chris Theodossiou, Everett G. Robert, Chandan Prasad, Thomas W. Axelrad, David V. Schapira, Jay D. Hunt> ;Cancer. 1999 Oct 15
6 citations
Treatment of Thrombotic Thrombocytopenic Purpura with the Cryosupernatant Fraction of Plasma: A Case Report and Review of the Literature
James Ellis, Chris Theodossiou, Paul Schwarzenberger> ;The American Journal of the Medical Sciences. 1999 Sep 1
18 citations
Cloning and characterization of the prostate-specific membrane antigen promoter.
David Good, Paul Schwarzenberger, James A. Eastham, Robert E. Rhoads, Jay D. Hunt, Michael Patrick Collins, Mark A. Batzer, Chris Theodossiou, Jay K. Kolls, Sidney R. ...> ;Journal of Cellular Biochemistry. 1999 Sep 1
21 citations
The Treatment of Malignant Mesothelioma with a Gene Modified Cancer Cell Line: A Phase I Study. Louisiana State University Medical Center, New Orleans
Principal Investigator: Paul Schwarzenberger, Co-Investigators: Lynn Harrison, Ann Weinacker, Aizen J. Marrogi, P Byrne, Rajagopal Ramesh, Chris Theodossiou, Richard G...> ;Human Gene Therapy. 1998 Nov 20
19 citations
Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma.
Paul Schwarzenberger, Dinghua Lei, Scott M. Freeman, Peng Ye, Ann Weinacker, Chris Theodossiou, Warren R. Summer, Jay K. Kolls> ;American Journal of Respiratory Cell and Molecular Biology. 1998 Aug 1
15 citations
Gene Therapy for Malignant Mesothelioma: A Novel Approach for an Incurable Cancer With Increased Incidence in Louisiana
Paul Schwarzenberger, Lynn Harrison, Ann Weinacker, R. Gaumer, Chris Theodossiou, Warren R. Summer, P. Ye, A. J. Marrogi, Rajagopal Ramesh, Scott M. Freeman, Jay K. Kolls> ;The Journal of the Louisiana State Medical Society. 1998 Apr 1
9 citations
Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics.
Paul Schwarzenberger, Jay D. Hunt, E Robert, Chris Theodossiou, Jay K. Kolls> ;Journal of Virology. 1997 Nov 1
1 citations
Chromosome 21 rearrangement in acute biphenotypic leukemia.
Chris Theodossiou, Angela Scalise, Lewis B. Silverman, Vesna Najfeld> ;Cancer Genetics and Cytogenetics. 1992 Nov 1
12 citations
del(5q) in acute lymphoblastic leukemia with biphenotypic and early progenitor phenotype.
Chris Theodossiou, Angela Scalise, Kevin Troy, Lewis B. Silverman, Eva Perdahl-Wallace, Vesna Najfeld> ;Cancer Genetics and Cytogenetics. 1992 Oct 15
DUPLICATION q21 TO q26 OF CHROMOSOME 3 IN A PATIENT WITH ACUTE MYELOGENOUS LEUKAEMIA‐M1
Vesna Najfeld, Angela Scalise, Nathaniel Wisch, Chris Theodossiou> ;British Journal of Haematology. 1992 Apr 1
Early stage breast cancer.
Theodossiou, C., Schwarzenberger, P., Espinozadelgado, I., Wynn, R., Schapira, D.> ;Oncol Rep. 1997 Nov 01
Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR.
Byrne, P., Huang, W., Wallace, V. M., Shean, M. K., Zhang, Z., Zhong, Q., Theodossiou, C., Blakesley, H., Kolls, J. K., Schwarzenberger, P.> ;Biotechniques. 2002 Feb
The effects of NSAIDs on breast cancer prognostic factors.
Schapira, D. V., Theodossiou, C., Lyman, G. H.> ;Oncol Rep. 1999 Feb 19
4 citations
Plasmacytoma in HIV Disease: Two Case Reports and Review of the Literature
Chris Theodossiou, Richard Burroughs, Raymond Wynn, Paul Schwarzenberger> ;The American Journal of the Medical Sciences. 1998 Nov 1
Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines.
Theodossiou, C., Cook, J. A., Fisher, J., Teague, D., Liebmann, J. E., Russo, A., Mitchell, J. B.> ;Int J Oncol. 1998 Apr
Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.
Temeck, B. K., Liebmann, J. E., Theodossiou, C., Steinberg, S. M., Cook, J. A., Metz, D. C., Shawker, T. H., Allegra, C. J., Russo, A., Pass, H. I.> ;Cancer. 1996 Jun 15
10 citations
Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3
C. Theodossiou, Glenn S. Kroog, S. E. Ettinghausen, Anthony W. Tolcher, Kenneth H. Cowan, Joyce A. O'Shaughnessy> ;Cancer. 1994 Nov 15
High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
Deguchi, Y., Yamanaka, Y., Theodossiou, C., Najfeld, V., Kehrl, J. H.> ;Leukemia. 1993 Mar
5 citations
CYTOMEGALOVIRUS ENTERITIS AFTER TREATMENT WITH 5‐FLUOROURACIL, LEUKOVORIN, CISPLATIN, AND α‐INTERFERON
C. Theodossiou, B. Temeck, H. Vargas, J. Yang, M. Vargas, S. Hahn, Harvey I. Pass> ;The American Journal of Gastroenterology. 1995 Jul 1
Join now to see all

Hospital Affiliations

Ochsner Medical CenterNew Orleans, Louisiana